| |
| |
|
| Insider
Information: |
Mcnab James R |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,433,180 |
|
|
Indirect Shares
|
101,021 |
|
|
| Direct
Value |
$335,126 |
|
|
|
Indirect Value
|
$41,449 |
|
|
| Total
Shares |
1,534,201 |
|
|
| Total
Value |
$376,575 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Curis Inc |
CRIS |
Director |
2017-05-05 |
879,688 |
2017-05-05 |
50,000 |
Premium* |
|
|
Echo Therapeutics Inc |
ECTE |
Director |
2003-10-09 |
551,823 |
2003-10-09 |
0 |
Premium* |
|
|
Titan Pharmaceuticals Inc |
TTNP |
Director |
2022-01-28 |
1,669 |
2022-01-28 |
51,021 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TTNP |
Titan Pharmaceuticals Inc |
Director |
– • – |
2022-01-28 |
4 |
A |
$0.00 |
$0 |
I/I |
51,021 |
51,021 |
0 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
Director |
– • – |
2018-09-21 |
4 |
B |
$0.25 |
$50,000 |
D/D |
200,000 |
300,000 |
2.39 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-05-05 |
4 |
AS |
$1.90 |
$30,721 |
I/I |
(16,176) |
50,000 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-05-04 |
4 |
AS |
$1.97 |
$59,159 |
I/I |
(30,100) |
66,176 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-05-03 |
4 |
AS |
$2.18 |
$65,544 |
I/I |
(30,000) |
96,276 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-05-02 |
4 |
AS |
$2.31 |
$82,314 |
I/I |
(35,646) |
126,276 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-05-01 |
4 |
AS |
$2.38 |
$90,709 |
I/I |
(38,113) |
161,922 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-04-28 |
4 |
AS |
$2.45 |
$105,015 |
I/I |
(42,949) |
200,035 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-04-27 |
4 |
AS |
$2.57 |
$95,624 |
I/I |
(37,202) |
242,984 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-04-26 |
4 |
AS |
$2.65 |
$86,648 |
D/D |
(32,738) |
879,688 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-04-26 |
4 |
AS |
$2.65 |
$52,442 |
I/I |
(19,814) |
280,186 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-04-25 |
4 |
AS |
$2.60 |
$148,306 |
D/D |
(56,940) |
912,426 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-04-24 |
4/A |
AS |
$2.56 |
$107,862 |
D/D |
(42,076) |
969,366 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-04-24 |
4 |
AS |
$2.56 |
$107,862 |
D/D |
(42,076) |
1,269,366 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-04-21 |
4/A |
AS |
$2.58 |
$117,841 |
D/D |
(45,705) |
1,011,442 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-04-21 |
4 |
AS |
$2.58 |
$117,841 |
D/D |
(45,705) |
1,311,442 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-04-20 |
4/A |
AS |
$2.66 |
$59,979 |
D/D |
(22,541) |
1,057,147 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-04-20 |
4 |
AS |
$2.66 |
$59,979 |
D/D |
(22,541) |
1,357,147 |
0 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
Director |
– • – |
2016-05-31 |
4 |
B |
$7.03 |
$140,600 |
I/I |
20,000 |
100,000 |
2.1 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
Director |
– • – |
2016-01-13 |
4 |
B |
$3.16 |
$51,707 |
I/I |
16,363 |
80,000 |
2.1 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
Director |
– • – |
2014-11-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
350,000 |
|
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2014-04-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
1,049,688 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2013-08-16 |
4 |
S |
$4.00 |
$200,000 |
I/I |
(50,000) |
50,000 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2013-08-16 |
4 |
B |
$4.00 |
$200,000 |
I/I |
50,000 |
250,000 |
2.1 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2012-12-20 |
5 |
GD |
$0.00 |
$0 |
I/I |
30,975 |
100,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
